Published in Am J Gastroenterol on October 27, 2009
Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int (2014) 1.40
Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci (2010) 1.01
Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays. Mol Cell Proteomics (2012) 0.96
The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol (2010) 0.93
Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol (2010) 0.90
Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol (2010) 0.89
Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways. J Autoimmun (2013) 0.87
Bromodomain proteins in HIV infection. Viruses (2013) 0.85
Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea: IL1R2, NPR2, AR, SP140 Methylation and Clinical Phenotype. Sleep (2016) 0.84
Role of autoimmunity in primary biliary cirrhosis. World J Gastroenterol (2012) 0.79
Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther (2015) 0.78
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights (2013) 0.78
SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis. J Immunol Res (2015) 0.77
Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis. PLoS One (2014) 0.77
Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis. World J Hepatol (2013) 0.77
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. World J Gastroenterol (2012) 0.77
Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol (2015) 0.75
Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140. Sci Immunol (2017) 0.75
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J (2007) 7.45
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol (2014) 4.18
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis (2013) 3.99
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum (2010) 2.90
Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) (2012) 2.84
Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol (2003) 2.69
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med (2007) 2.58
Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA (2005) 2.51
Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol (2007) 2.35
RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA (2006) 1.89
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis (2005) 1.83
Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol (2010) 1.70
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70
Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis (2003) 1.65
STING Millennium: A web-based suite of programs for comprehensive and simultaneous analysis of protein structure and sequence. Nucleic Acids Res (2003) 1.64
Worldwide prevalence of head lice. Emerg Infect Dis (2008) 1.58
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57
Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol (2002) 1.56
Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood (2011) 1.49
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther (2010) 1.49
It's all in the face: amiodarone-induced myxedema and skin pigmentation. Eur J Dermatol (2006) 1.47
New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis (2008) 1.45
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40
Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int (2014) 1.40
Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression. Clin Cancer Res (2004) 1.38
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci (2003) 1.37
Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2. Mol Cell Biol (2011) 1.32
An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis (2008) 1.29
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J (2005) 1.28
Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol (2002) 1.23
Binding and interstitial penetration of liposomes within avascular tumor spheroids. Int J Cancer (2004) 1.21
Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest (2013) 1.17
Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA (2007) 1.16
Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol (2004) 1.14
Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2013) 1.14
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10
Diversity of soil fungal communities of Cerrado and its closely surrounding agriculture fields. Arch Microbiol (2008) 1.10
Bacterial community associated with healthy and diseased reef coral Mussismilia hispida from eastern Brazil. Microb Ecol (2010) 1.10
Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci (2008) 1.08
Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol (2007) 1.07
A "One Health" surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp Immunol Microbiol Infect Dis (2012) 1.07
Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol (2006) 1.06
Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. J Immunol (2005) 1.06
Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Mod Rheumatol (2011) 1.06
The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis. J Rheumatol (2005) 1.05
Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol (2002) 1.03
Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet (2006) 1.03
Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids. Cancer Res (2003) 1.02
Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology (2005) 1.02
Global transcriptome analysis of two wild relatives of peanut under drought and fungi infection. BMC Genomics (2012) 1.01
Processing body autoantibodies reconsidered. RNA (2006) 1.00
The liver in brucellosis. Clin Gastroenterol Hepatol (2007) 1.00
Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control (2010) 1.00
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis (2008) 1.00
IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor. Int J Rheumatol (2012) 0.99
Cell-mediated immunity in human brucellosis. Microbes Infect (2010) 0.99
Eggs regulate sperm flagellar motility initiation, chemotaxis and inhibition in the coral Acropora digitifera, A. gemmifera and A. tenuis. J Exp Biol (2006) 0.98
Management of rheumatoid arthritis: the 2012 perspective. Mod Rheumatol (2012) 0.98
2-methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J Orthop Res (2007) 0.97
Brucellosis in infant after familial outbreak. Emerg Infect Dis (2008) 0.96
Physical and functional interactions between PML and MDM2. J Biol Chem (2003) 0.96
Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96
Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol (2005) 0.95
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95
Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev Mol Med (2007) 0.93
Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan. Rheumatol Int (2010) 0.93